Aerial view of NHS Arrowe Park Teaching Hospital buildings (Credit: JSvideos / Shutterstock.com)
Waiting times for cancer, elective and diagnostic pathways at Wirral University Teaching Hospital NHS Foundation Trust have been “significantly impacted” by…
Continue Reading
The confluence of new technologies with artificial intelligence (AI) and machine learning (ML) analytical techniques is rapidly advancing the field of precision oncology, promising to improve diagnostic approaches and therapeutic strategies for patients with…
Continue Reading
What You Should Know:
– Oatmeal Health, an innovator in AI-driven cancer screening launches its AI-powered radiology risk stratification platform for lung cancer.
– The solution provides a fully reimbursable second-opinion diagnostic tool covered by Medicare,…
Continue Reading
Key Medical Discoveries Through ISS Research
SpaceX’s 31st Commercial Resupply Services mission to the International Space Station (ISS) has brought groundbreaking biotechnology research possibilities. The mission carried approximately 50 research payloads, focusing on advancing medical…
What You Should Know:
– Owkin, an AI-powered biotech company, today announced the dosing of the first patient in its Phase I clinical trial of OKN4395, a novel cancer therapy designed to restore immune function…
Continue Reading
What You Should Know:
– C the Signs, a developer of AI-powered cancer detection solutions, today announced an $8 million funding round led by Khosla Ventures.
– The investment will fuel the company’s expansion from the…
Continue Reading
England’s Patient Safety Commissioner Dr Henrietta Hughes OBE is the latest confirmed keynote for Rewired 2025.Before her national role as independent patient champion Dr Hughes was the National Guardian for the NHS and a…
Continue Reading
Groundbreaking AI Study Transforms Cancer Diagnostics
Lunit, in partnership with Japan’s National Cancer Center Hospital East (NCCHE), has published breakthrough research in the Journal of Clinical Oncology Precision Oncology. Their study demonstrates how AI-powered pathology…
Top News
AI-powered cancer drug discovery startup Manas AI launches with a $25 million seed funding round.
The co-founders are LinkedIn co-founder and venture capitalist Reid Hoffman and oncologist-author Siddhartha Mukherjee, DPhil, MD, who wrote Pulitzer…
Simon Rasalingham, chief executive of Behold.ai (Credit: Prix Galien International)
UK-based digital health start-up Behold.ai has entered administration after failing to win any contracts under the government’s AI Diagnostic Fund.
Behold.ai supplies lung cancer AI…
